Selective Serotonin Reuptake Inhibitors: A New Modality for the Treatment of Lymphoma/Leukaemia?
BMC Pharmacology
doi 10.1186/1471-2210-7-s2-a8
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2007
Authors
Publisher
Springer Science and Business Media LLC